These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8305365)

  • 1. Central pontine myelinolysis: report of two occurrences after cisplatin-containing chemotherapy for nasopharyngeal carcinoma.
    Yau TK; Yiu HY; Lee WM
    Clin Oncol (R Coll Radiol); 1993; 5(6):395-6. PubMed ID: 8305365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Chi KH; Chan WK; Shu CH; Law CK; Chen SY; Yen SH; Chen KY
    Cancer; 1995 Dec; 76(11):2186-92. PubMed ID: 8635020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy with continuous infusion of cisplatin and 5-fluorouracil, with or without leucovorin, for locally advanced nasopharyngeal carcinoma.
    Fonseca E; Cruz JJ; Rodríguez CA; Gómez-Bernal A; Martín G; Sánchez P; Nieto A; Soria P; Vega MJ; Muñoz A; Pardal JL
    J Infus Chemother; 1996; 6(4):217-20. PubMed ID: 9229319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
    Lin JC; Jan JS; Chen KY; Hsu CY; Liang WM; Wang WY
    Head Neck; 2003 Jun; 25(6):438-50. PubMed ID: 12784235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction Methotrexate, Cisplatin, and 5-Fluorouracil Versus Cisplatin and 5-Fluorouracil Followed by Radiotherapy in Pediatric Nasopharyngeal Carcinoma: A Retrospective Analysis in a Tertiary Cancer Center.
    Al Mousa A; Abu-Hijlih R; Salem A; Sultan I; Mula-Hussain L; Ismael T; Mohamad I
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e437-e442. PubMed ID: 28816803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse large B-cell lymphoma presenting with central pontine myelinolysis: a case report.
    Kawata E; Isa R; Yamaguchi J; Tanba K; Tsutsumi Y; Nagakane Y; Uchiyama H; Akaogi T; Kobayashi Y; Uoshima N
    J Med Case Rep; 2015 Jun; 9():131. PubMed ID: 26044457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortobifemoral embolism in an 18-year old patient following cisplatin and 5-fluorouracil chemotherapy for nasopharyngeal carcinoma.
    Heinrich N; Born M; Hoebert E; Verrel F; Simon A; Bode U; Fleischhack G
    Vasa; 2010 Aug; 39(3):271-3. PubMed ID: 20799166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary report of outpatient weekly adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
    Lin JC; Jan JS; Hsu CY
    Am J Clin Oncol; 1996 Dec; 19(6):624-7. PubMed ID: 8931685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
    Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akinetic-rigid syndrome due to extrapontine and pontine myelinolysis following appropriate correction of hyponatraemia.
    de Souza A
    J Clin Neurosci; 2011 Apr; 18(4):587-9. PubMed ID: 21273078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy regimens containing taxanes or fluorouracil in nasopharyngeal carcinoma: Which better?
    Mi JL; Zhang B; Pan YF; Su YX; Fan JF; Liao SF; Qin XL; Yao DC; Tang HY; Jiang W
    Oral Oncol; 2017 Nov; 74():34-39. PubMed ID: 29103749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
    Chua DT; Sham JS; Au GK
    Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major toxicity of cisplatin, fluorouracil, and leucovorin following chemoradiotherapy in patients with nasopharyngeal carcinoma.
    Celik I; Kars A; Ozyar E; Tekuzman G; Atahan L; Firat D
    J Clin Oncol; 1996 Mar; 14(3):1043-4. PubMed ID: 8622011
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.
    Lee AW; Tung SY; Chua DT; Ngan RK; Chappell R; Tung R; Siu L; Ng WT; Sze WK; Au GK; Law SC; O'Sullivan B; Yau TK; Leung TW; Au JS; Sze WM; Choi CW; Fung KK; Lau JT; Lau WH
    J Natl Cancer Inst; 2010 Aug; 102(15):1188-98. PubMed ID: 20634482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apropos of two recently published randomized trials of induction chemotherapy in nasopharyngeal and piriform sinus carcinoma].
    de Crevoisier R; Mazeron JJ
    Bull Cancer Radiother; 1996; 83(3):174-6. PubMed ID: 8977570
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
    Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
    Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Schwarz LR
    Cancer; 1996 Aug; 78(3):566-7. PubMed ID: 8697406
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypopituitarism and hyponatremia in a case with nasopharyngeal carcinoma.
    Kokatsu T; Tsukuda M
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):347-51. PubMed ID: 7838487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent response to cis-platinum-based chemotherapy in patients with recurrent or previously untreated advanced nasopharyngeal carcinoma.
    Al-Kourainy K; Crissman J; Ensley J; Kish J; Kelly J; Al-Sarraf M
    Am J Clin Oncol; 1988 Aug; 11(4):427-30. PubMed ID: 2457306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma].
    Xie FY; Qi SN; Hu WH; Zou GR; Peng M; Li JS
    Ai Zheng; 2007 Aug; 26(8):880-4. PubMed ID: 17697552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.